Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204866 | SCV000261637 | benign | Adams-Oliver syndrome 5 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000770636 | SCV000319563 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705178 | SCV000525686 | likely benign | not provided | 2021-07-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16729972, 25194568) |
Center for Human Genetics, |
RCV000660156 | SCV000782150 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770636 | SCV000902087 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000204866 | SCV002554520 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000602259 | SCV002554521 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000420267 | SCV004029537 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705178 | SCV004162036 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7, BS2 |
ARUP Laboratories, |
RCV001705178 | SCV004563069 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001705178 | SCV005228688 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000602259 | SCV000734677 | likely benign | Aortic valve disease 1 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000420267 | SCV001807640 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001705178 | SCV001959076 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001705178 | SCV001965599 | likely benign | not provided | no assertion criteria provided | clinical testing |